mTOR pathway and Ca2+ stores mobilization in aged smooth muscle cells

Aging

Volumn 5, Issue 5, 2013, Pages 339-346

  Martín Cano, Francisco E ^a   Camello Almaraz, Cristina ^a   Hernandez, David ^a   Pozo, Maria J ^a   Camello, Pedro J ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Colon; FKBP12; mTOR; Smooth muscle

Indexed keywords

EID: 84880412025     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100555     Document Type: Article

References (46)

1. Blagosklonny MV. Answering the ultimate question "What is the Proximal Cause of Aging?". Aging (Albany. NY). 2012; 4:899- 916.
2. Blagosklonny MV. Aging: ROS or TOR. Cell Cycle. 2008; 7:3344- 3354.
3. Camello PJ, Camello-Almaraz C, and Pozo MJ, Pharmacological approaches to improve ageing. In: Pharmacology,(Ed. Gallelli L), pp. 257-282. InTech, 2012.
4. Laplante M and Sabatini DM. mTOR signaling at a glance. J. Cell Sci. 2009; 122:3589-3594.
5. Gant JC, Chen KC, Norris CM, Kadish I, Thibault O, Blalock EM, Porter NM, and Landfield PW. Disrupting function of FK506- binding protein 1b/12.6 induces the Ca(2)+-dysregulation aging phenotype in hippocampal neurons. J. Neurosci. 2011; 31:1693- 1703.
6. Hoeffer CA, Tang W, Wong H, Santillan A, Patterson RJ, Martinez LA, Tejada-Simon MV, Paylor R, Hamilton SL, and Klann E. Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior. Neuron. 2008; 60:832-845.
7. Leontieva OV and Blagosklonny MV. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence. Aging (Albany. NY). 2010; 2:924-935.
8. Blagosklonny MV. Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging. Aging (Albany. NY). 2012; 4:159-165.
9. Yang SB, Tien AC, Boddupalli G, Xu AW, Jan YN, and Jan LY. Rapamycin ameliorates age-dependent obesity associated with increased mTOR signaling in hypothalamic POMC neurons. Neuron. 2012; 75:425-436.
10. Leontieva OV, Paszkiewicz GM, and Blagosklonny MV. Mechanistic or mammalian target of rapamycin (mTOR) may determine robustness in young male mice at the cost of accelerated aging. Aging (Albany. NY). 2012; 4:899-916.
11. Toescu EC and Verkhratsky A. Parameters of calcium homeostasis in normal neuronal ageing. J. Anat. 2000; 197 Pt 4:563-569.
12. 2+ release. J. Neurosci. 2006; 26:3482-3490.
13. Thibault O, Gant JC, and Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell. 2007; 6:307-317.
14. 2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J. Cell Mol. Med. 2004; 8:181-190.
15. Toescu EC and Vreugdenhil M. Calcium and normal brain ageing. Cell Calcium. 2010; 47:158-164.
16. Martinez-Serrano A, Blanco P, and Satrustegui J. Calcium binding to the cytosol and calcium extrusion mechanisms in intact synaptosomes and their alterations with aging. J. Biol. Chem. 1992; 267:4672-4679.
17. 2+ extrusion in aged smooth muscle cells. Biochem. Pharmacol. 2007; 74:860-869.
18. Gomez-Pinilla PJ, Camello-Almaraz C, Moreno R, Camello PJ, and Pozo MJ. Melatonin treatment reverts age-related changes in Guinea pig gallbladder neuromuscular transmission and contractility. J. Pharmacol. Exp. Ther. 2006; 319:847-856.
19. Xiong Z, Sperelakis N, Noffsinger A, and Fenoglio-Preiser C. Changes in calcium channel current densities in rat colonic smooth muscle cells during development and aging. Am. J. Physiol. 1993; 265:C617-C625.
20. Howlett SE, Grandy SA, and Ferrier GR. Calcium spark properties in ventricular myocytes are altered in aged mice. Am. J. Physiol Heart Circ. Physiol. 2006; 290:H1566-H1574.
21. Del CC, Ostrovskaya O, McAllister CE, Murray K, Hatton WJ, Gurney AM, Spencer NJ, and Wilson SM. Effects of aging on Ca2+ signaling in murine mesenteric arterial smooth muscle cells. Mech. Ageing Dev. 2006; 127:315-323.
22. Rubio C, Moreno A, Briones A, Ivorra MD, D'Ocon P, and Vila E. Alterations by age of calcium handling in rat resistance arteries. J. Cardiovasc. Pharmacol. 2002; 40:832-840.
23. Lopes GS, Ferreira AT, Oshiro ME, Vladimirova I, Jurkiewicz NH, Jurkiewicz A, and Smaili SS. Aging-related changes of intracellular Ca2+ stores and contractile response of intestinal smooth muscle. Exp. Gerontol. 2006; 41:55-62.
24. Xiong J, Camello PJ, Verkhratsky A, and Toescu EC. Mitochondrial polarisation status and [Ca2+]i signalling in rat cerebellar granule neurones aged in vitro. Neurobiol. Aging. 2004; 25:349-359.
25. 2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells. J. Cell Biochem. 2011; 112:723-733.
26. Dargan SL, Lea EJ, and Dawson AP. Modulation of type-1 Ins(1,4,5)P3 receptor channels by the FK506-binding protein, FKBP12. Biochem. J. 2002; 361:401-407.
27. 2+ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR. Br. J. Pharmacol. 2009; 158:1112-1120.
28. 2+ release by mTOR and calcineurin. J. Cell Sci. 2005; 118:5443-5451.
29. Macmillan D. FK506 binding proteins: Cellular regulators of intracellular Ca(2+) signalling. Eur J. Pharmacol. 2013; 700:181- 193.
30. Chen Y, Wang J, Cai J, and Sternberg P. Altered mTOR signaling in senescent retinal pigment epithelium. Invest Ophthalmol. Vis. Sci. 2010; 51:5314-5319.
31. Copp J, Manning G, and Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res. 2009; 69:1821-1827.
32. Saitoh M, Pullen N, Brennan P, Cantrell D, Dennis PB, and Thomas G. Regulation of an activated S6 kinase 1 variant reveals a novel mammalian target of rapamycin phosphorylation site. J. Biol. Chem. 2002; 277:20104-20112.
33. 2+ increases in guinea-pig colonic smooth muscle cells. J. Physiol. 2005; 569:533-544.
34. Zhang LB and Buxton IL. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways. Mol. Pharmacol. 1991; 40:952-959.
35. 2+ release in colonic but not aortic smooth muscle. Cell Calcium. 2008; 43:539-549.
36. Niemann B, Pan R, Teschner M, Boening A, Silber RE, and Rohrbach S. Age and obesity-associated changes in the expression and activation of components of the AMPK signaling pathway in human right atrial tissue. Exp. Gerontol. 2013; 48:55- 63.
37. Kadish I, Thibault O, Blalock EM, Chen KC, Gant JC, Porter NM, and Landfield PW. Hippocampal and cognitive aging across the lifespan: a bioenergetic shift precedes and increased cholesterol trafficking parallels memory impairment. J. Neurosci. 2009; 29:1805-1816.
38. Harries LW, Fellows AD, Pilling LC, Hernandez D, Singleton A, Bandinelli S, Guralnik J, Powell J, Ferrucci L, and Melzer D. Advancing age is associated with gene expression changes resembling mTOR inhibition: evidence from two human populations. Mech. Ageing Dev. 2012; 133:556-562.
39. Passtoors WM, Beekman M, Deelen J, van der BR, Maier AB, Guigas B, Derhovanessian E, van HD, de Craen AJ, Gunn DA, Pawelec G, and Slagboom PE. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell. 2013; 12:24-31.
40. 2+ currents in human colonic smooth muscle cells. Am. J. Physiol. 1995; 269:G378-G385.
41. Mekahli D, Bultynck G, Parys JB, De SH, and Missiaen L. Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb. Perspect. Biol. 2011; 3.
42. 2+ to gene expression. Gen. Comp Endocrinol. 2010; 169:123-129.
43. Morales S, Diez A, Puyet A, Camello P, Camello-Almaraz C, Bautista J, and Pozo MJ. Calcium controls smooth muscle TRPC gene transcription via the CAMK/calcineurin-dependent pathways. Am. J. Physiol Cell Physiol. 2006.
44. 2+ sparks in aging skeletal and cardiac muscle. Ageing Res. Rev. 2008; 7:177-188.
45. 2+ concentration in the guinea pig. Am. J. Physiol. 1993; 264:G624-G629.
46. Gomez-Pinilla PJ, Pozo MJ, and Camello PJ. Aging differentially modifies agonist-evoked mouse detrusor contraction and calcium signals. Age (Dordr. ). 2011; 33:81-88.